The California Institute for Regenerative Medicine (CIRM) is supporting innovative research into neuro diseases, including a project examining how air pollution may contribute to autism. Through the Research using Multidisciplinary, Innovative approaches in Neuro Diseases (ReMIND) program, Stuart Lipton, MD, PhD, and co-investigators Tomo Nakamura, PhD, John Yates, PhD, Marisa Roberto, PhD, and Nik Schork, … Continue reading The Link Between Air Pollution and Autism
Neuro Research
Using Genetic Sequencing and AI to Identify and Treat Schizophrenia
Top left to right: Tomasz Nowakowski, PhD, and Nevan Krogan, PhD Bottom left to right: Aparna Bhaduri, PhD; Matt State, PhD; Alice Ting, PhD; Trey Ideker, PhD; Willow Coyote-Maestas, PhD A UC San Francisco research team funded by the California Institute for Regenerative Medicine (CIRM) is using genetic sequencing and AI to identify and treat … Continue reading Using Genetic Sequencing and AI to Identify and Treat Schizophrenia
Upcoming Funding Opportunity: ReMIND-L Awards
The California Institute for Regenerative Medicine (CIRM) is pleased to announce ReMIND-L, the first funding opportunity under CIRM’s ReMIND Program – a new discovery stage initiative supporting foundational research in the study of neuropsychiatric diseases. Applications are due March 5, 2024 by 2:00 p.m. PST. Applications will be available mid-December 2023 but no later than two months … Continue reading Upcoming Funding Opportunity: ReMIND-L Awards
CIRM approves new plan to invest $110 million for neuropsychiatric disease research
The California Institute for Regenerative Medicine (CIRM) approved a new program called ReMIND at its September ICOC meeting. The program will award up to $110 million to advance basic research in neuropsychiatric diseases—one of California’s largest investments in this area. ReMIND (Research using Multidisciplinary, Innovative Approaches in Neuro Diseases) aims to accelerate discoveries that improve … Continue reading CIRM approves new plan to invest $110 million for neuropsychiatric disease research